Spontaneous NLRP3 inflammasome-driven IL-1-ß secretion is induced in severe COVID-19 patients and responds to anakinra treatment.
J Allergy Clin Immunol
; 150(4): 796-805, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-35835255
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Inflammasomes
/
COVID-19 Drug Treatment
Limits:
Humans
Language:
En
Journal:
J Allergy Clin Immunol
Year:
2022
Type:
Article
Affiliation country:
Italy